Cargando…
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
Leukemia and lymphoma are systemic malignancies that represent half of all childhood cancers, though 90% occur in adults. Various treatment options are available, but therapy is mainly systemic chemotherapy plus appropriate monoclonal antibodies. In certain situations radiotherapy and bone marrow t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Applied Systems srl
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535816/ https://www.ncbi.nlm.nih.gov/pubmed/26280017 http://dx.doi.org/10.15190/d.2014.6 |